Notably, recent research indicates that tumor cells can also express CCL25 [41, 42], potentially promoting the infiltration of cytotoxic, CCR9-expressing tumor-infiltrating lymphocytes into the tumor microenvironment, thereby enhancing anticancer effects [43, 44]. The gene discussed is CCL25; the disease is neoplasm.